AG Grewal Announces Action to Reduce Risk of Fatal Overdoses During COVID-19 Crisis: Administrative Order from Division of Consumer Affairs Requires NJ Practitioners to Co-Prescribe Naloxone to Certain At-Risk Opioid Patients During COVID-19 Emergency
dc.contributor.author | New Jersey. Office of the Attorney General | |
dc.contributor.author | Grewal, Gurbir S. | |
dc.contributor.author | Rodriguez, Paul R. | |
dc.contributor.author | Joyce, Sharon M. | |
dc.date.accessioned | 2020-10-29T18:17:54Z | |
dc.date.available | 2020-10-29T18:17:54Z | |
dc.date.issued | 2020-05-21 | |
dc.description | This record contains the associated New Jersey Division of Community Affairs Administrative Order No. 2020-08 Administrative Order and Notice of Rule Adoption Pursuant to P.L., c 18 Naloxone Prescribing by Health Care Practitioners | en_US |
dc.identifier.govdoc | 974.905 L464 | |
dc.identifier.uri | https://hdl.handle.net/10929/68549 | |
dc.language.iso | en_US | en_US |
dc.publisher | Trenton, N.J.: Office of the Attorney General | en_US |
dc.subject | New Jersey | en_US |
dc.subject | Covid 19 | en_US |
dc.subject | Novel coronavirus | en_US |
dc.subject | Law enforcement | en_US |
dc.subject | Health and safety | en_US |
dc.title | AG Grewal Announces Action to Reduce Risk of Fatal Overdoses During COVID-19 Crisis: Administrative Order from Division of Consumer Affairs Requires NJ Practitioners to Co-Prescribe Naloxone to Certain At-Risk Opioid Patients During COVID-19 Emergency | en_US |